MEI Pharma Adds Cancer Drug Development Veteran Tom Reynolds to Board of Directors

[at noodls] – February 11, 2013 San Diego – MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today the appointment of Thomas C. Reynolds, … more

View todays social media effects on MEIP

View the latest stocks trending across Twitter. Click to view dashboard

See who MEI is hiring next, click here to view